Kiyohara C, Washio M, Horiuchi T, Tada Y, Asami T, Ide S, Atsumi T, Kobashi G, Takahashi H, Kyushu Sapporo SLE (KYSS) Study Group: Cigarette smoking, STAT4 and TNFRSF1B polymorphisms, and systemic lupus erythematosus in a Japanese population. J Rheumatol 2009, 36:2195–2203.PubMedCrossRef 16. Horiuchi T, Kiyohara C, Tsukamoto H, Sawabe T, Furugo I, Yoshizawa S, Ueda A, Tada Y, Nakamura T, Kimoto

Y, Mitoma H, Harashima S, Yoshizawa S, Shimoda T, Okamura S, Nagasawa K, Harada M: A functional M196R polymorphism of tumour necrosis factor PXD101 clinical trial receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis. Ann Rheum Dis 2007, 66:320–324.PubMedCrossRef 17. Horiuchi T, Washio M, Kiyohara C, Tsukamoto H, Tada Y, Asami T, Ide S, Kobashi G, Takahashi H, Kyushu Sapporo SLE Study Group: Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study. Rheumatology (Oxford) 2009, 48:1045–1049.CrossRef 18. Barton A, John S, Ollier WE, selleck screening library Silman A, Worthington J: Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor

II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum 2001, 44:61–65.PubMedCrossRef 19. Glossop JR, Dawes PT, Hassell AB, Mattey DL: Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes. J Rheumatol 2005, 32:1673–1678.PubMed 20. Vakkila J, Lotze MT: Inflammation and necrosis promote tumour growth. Nature Rev Immunol 2004, 4:641–648.CrossRef 21. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57–70.PubMedCrossRef 22. Corazza N, Kassahn D, Jakob S, Badmann A, Brunner T: TRAIL-induced buy Vorinostat apoptosis: between tumor therapy and immunopathology. Ann N Y Acad Sci 2009, 1171:50–58.PubMedCrossRef 23. Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, Lagiou P, Trichopoulos D, Ahrens W, Pigeot I, Merletti F, Richiardi L, Talamini R, Barzan L, Macfarlane GJ, Macfarlane TV,

Holcátová I, Bencko V, Benhamou S, Bouchardy C, Kjaerheim K, Lowry R, Agudo A, Castellsagué X, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy CM, Marron M, Brennan P: Genetic associations of 115 polymorphisms with NCT-501 in vivo cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res 2009, 69:2956–2965.PubMedCrossRef 24. Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S, Vylliotis A, Derka S, Vassiliou S, Nkenke E, Patsouris E: Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 2008, 134:821–832.PubMedCrossRef 25. Colakogullari M, Ulukaya E, Yilmaztepe Oral A, Aymak F, Basturk B, Ursavas A, Oral HB: The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients.